Oracle Continues to Receive Analyst Optimism, Despite Restructuring Costs
Oracle (ORCL) continues to attract analyst optimism, despite revealing higher restructuring costs. This optimism is also echoed towards Broadcom (AVGO), with fresh analyst optimism. On the other hand, investors are unsure whether to buy ORCL stock after Oracle revealed higher restructuring costs.
ORCL continues to attract Wall Street optimism even as the company disclosed a significant increase in restructuring costs. In its FY26 Q3 results reported March 10, Oracle set aside an additional $500 million for restructuring, bringing the total fiscal 2026 restructuring budget to $2.1 billion — up from the $1.6 billion announced in December 2025. Despite these elevated costs, shares jumped after the company beat fiscal Q3 expectations.
Analysts remain broadly constructive on the stock, with Wall Street maintaining a Strong Buy consensus based on 28 Buy ratings and four Holds. Guggenheim highlighted that Oracle's heavy investments in AI data centers are expected to pay off over the medium term. Stifel trimmed its price target to $220 from $275 but kept a Buy rating, citing expected EPS growth driven by infrastructure-as-a-service momentum and SaaS application strength heading into fiscal 2027.
However, RBC Capital analyst Rishi Jaluria flagged that the restructuring expenses may signal broader layoffs, noting that "restructuring is often code for layoffs". Meanwhile, AVGO is also seeing fresh analyst optimism in the semiconductor space. For Oracle investors, the key question remains whether the company's aggressive cloud and AI infrastructure buildout can generate returns fast enough to offset the near-term margin pressure from restructuring.
Powered by SentiSense - Intelligent Market Analysis